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ABSTRACT

The primary objective of this research project was to evaluate the effects of three
different compositions of bioactive glass microfibers (45S5, 13-93B3, and 13-93B3Cu)
and bioactive glass beads (13-93, 13-93B3, and 13-93B3Cu) on angiogenesis in
subcutaneous tissue in the SKH1 ‘hairless’ mouse. Microvascular responses to the
bioactive glass implants were investigated via three experimental approaches:
noninvasive vital imaging of microvasculature in dorsal skin windows; quantitative
histomorphometry of microvascular densities; and quantitative PCR measurements of
mRNA expression of pro-angiogenic cytokines VEGF and FGF-2. The live imaging of
dorsal skin window preparations in the hairless SKH1 showed the formation of a halolike structure infused with vessels in soft tissue surrounding borate-based 13-93B3 and
13-93B3Cu glass beads two weeks after implantation. This response was not observed
around silicate-based 13-93 glass beads. Quantitative histomorphometry of tissue
implanted with 45S5, 13-93B3, and 13-93B3Cu glass microfiber plugs revealed
microvascular densities that were 1.6-, 2.3-, and 2.7-fold higher, respectively compared
to the sham control tissues whereas the 13-93, 13-93B3, and 13-93B3Cu glass beads
produced a 1.3-, 1.6-, and 2.5-fold increase, respectively, compared to the sham control.
Quantitative PCR measurements indicate a marginally significant increase in expression
of VEGF mRNA in skin tissues with 13-93B3Cu. This latter outcome supports the
project hypothesis that 13-93B3Cu glass induces VEGF expression followed by
neovascularization, a key process of wound healing.
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ABSTRACT

The primary objective of this research project was to evaluate the effects of three
different compositions of bioactive glass microfibers (45S5, 13-93B3, and 13-93B3Cu)
and bioactive glass beads (13-93, 13-93B3, and 13-93B3Cu) on angiogenesis in
subcutaneous tissue in the SKH1 ‘hairless’ mouse. Microvascular responses to the
bioactive glass implants were investigated via three experimental approaches:
noninvasive vital imaging of microvasculature in dorsal skin windows; quantitative
histomorphometry of microvascular densities; and quantitative PCR measurements of
mRNA expression of pro-angiogenic cytokines VEGF and FGF-2. The live imaging of
dorsal skin window preparations in the hairless SKH1 showed the formation of a halolike structure infused with vessels in soft tissue surrounding borate-based 13-93B3 and
13-93B3Cu glass beads two weeks after implantation. This response was not observed
around silicate-based 13-93 glass beads. Quantitative histomorphometry of tissue
implanted with 45S5, 13-93B3, and 13-93B3Cu glass microfiber plugs revealed
microvascular densities that were 1.6-, 2.3-, and 2.7-fold higher, respectively compared
to the sham control tissues whereas the 13-93, 13-93B3, and 13-93B3Cu glass beads
produced a 1.3-, 1.6-, and 2.5-fold increase, respectively, compared to the sham control.
Quantitative PCR measurements indicate a marginally significant increase in expression
of VEGF mRNA in skin tissues with 13-93B3Cu. This latter outcome supports the
project hypothesis that 13-93B3Cu glass induces VEGF expression followed by
neovascularization, a key process of wound healing.
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I.

INTRODUCTION

Each year approximately 6.5 million people in the United States receive treatment
for non-healing chronic skin wounds. This is a significant health care problem that costs
an estimated $25 billion dollars annually [1]. Chronic skin wounds are wounds that do
not heal within three months and consist of three primary types: venous ulcers, diabetic
ulcers, and pressure ulcers [2]. Chronic wounds frequently become infected and
gangrenous, often resulting in amputation and dramatically higher mortality rates [3].
Diabetic ulcers of the foot present a special challenge due to the characteristically
diminished blood flow of diabetic patients, a characteristic that impedes the healing of
soft tissue wounds [4].
Wound healing consists of three overlapping phases which include inflammation,
proliferation, and maturation [5-7]. The inflammatory phase begins with hemostasis.
This halts the ongoing loss of blood and fluid loss, and continues with release of
cytokines that make the wound hypoxic, thus creating an environment that recruits T cells
[8-9]. The proliferation phase includes the release of specific growth factors that trigger
the formation of granulation tissue. The newly formed blood vessels of this tissue are
responsible for its reddish, granular appearance which is the basis of the tissue name.
The maturation phase includes the remodeling and realignment of collagen fibers along
lines of tension, creating an increase in tensile strength of wound tissue. The full cause of
impaired wound healing in chronic soft tissue wounds remains uncertain despite
extensive research.
Neovascularization or angiogenesis plays a crucial role in the healing of soft
tissue wounds. The importance of this process is emphasized by the discovery that
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insufficient angiogenesis is a hallmark of chronic wound healing as seen in diabetic
patients with chronic venous stasis wounds [10-17]. The finding that specific angiogenic
cytokines are often absent or deficient in patients with chronic wounds has prompted the
use of various pro-angiogenic growth factors in clinical trials for the treatment of chronic
wounds [18]. The pro-angiogenic growth factor platelet derived growth factor (PDGF) is
the active component of a topical gel (Becaplermin) for the treatment of lower extremity
ulcers [19]. Other experimental trials with positive results have involved the use of
vascular endothelial growth factor A (VEGFA) and fibroblast growth factor B (bFGF or
FGF2), two of the known positive regulators of angiogenesis [20,21]. Currently, PDGF
remains the only growth factor approved by the FDA for treating non-healing chronic
wounds in humans [22].
The standard procedures currently used to treat and manage skin wounds include
the administration of antibiotics, debridement of necrotic tissue with repeat applications
of wound dressings, compression therapy, plus various nutritional supplements [23-26].
These conventional procedures often demonstrate limited efficacy in the treatment
chronic wounds. This limited effectiveness has prompted use of more aggressive
treatment options such as negative pressure treatments [27], hyperbaric chambers [28],
oxygen therapy [29], and the transplantation of cultured human dermis [30,31]. Although
these more aggressive treatments have had limited success, they have a minimal impact
due to their limited availability, excessively high cost, and other factors.
A new, simpler, and less expensive approach to cytokine-induced angiogenesis is
the incorporation of pro-angiogenic ions in wound treatment materials. A number of ions
including copper, cobalt, boron, zinc, and others have been shown to have a physiological
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role in angiogenesis [32,33]. Using dissolvable materials containing one or more of these
pro-angiogenic ions could be effective for localized delivery of angiogenic ions. Boratebased bioactive glass was recently tested as a delivery device for angiogenic ions in soft
tissue repair [34]. Bioactive glass scaffolds doped with copper and other elements were
subcutaneously implanted into laboratory rats and left for six weeks. Analysis of tissues
implanted with scaffolds prepared from a borate-based glass designated 13-93B3 and 1393B3 with 0.4% CuO showed a higher density of microvasculature than those with silicabased glass fiber scaffolds [34]. There were however, no sham control tissues included
for baseline comparison in that study.
Based on the promising outcome of the murine model, an initial clinical
evaluation of the use of borate glass microfibers in wound healing was recently
performed by the wound care unit at Phelps County Regional Medical Center (PCRMC).
That study included 12 volunteers with chronic venous stasis wounds that were treated
topically with repeat microfibrous dressings of 13-93B3 or 13-93B3Cu glass microfibers.
The treatments with both glasses were found to help accelerate the healing of previously
unresponsive dermal wounds. The chronic wounds were completely healed in 8 out of 12
patients in the clinical study. The clinical staff noticed during daily observations that the
13-93B3 glass appeared to promote re-epithelialization while 13-93B3Cu microfibers
appeared to promote granulation in wound healing [35].
A follow up quantitative evaluation of the response of soft tissue to implants of
borate-based microfibrous glass was recently conducted in a rodent model [36].
Compressed mats of microfibrous glass were subcutaneously implanted in Sprague
Dawley rats and histologically evaluated at two, three, and four week intervals. The
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istomorphometric results obtained indicated that borate-based microfibrous glass doped
with copper did effectively stimulate angiogenesis.
This study was undertaken to investigate the underlying mechanism of the
angiogenic effect of bioactive borate glass. The study involved use of the SKH1 ‘hairless’
mouse with research objective at three distinct biological levels including the
macroscopic, tissue, and molecular levels. The macroscopic objective involved real-time
imaging of localized tissue responses to bioactive glass using transilluminated dorsal skin
fold windows. The second objective was a histomorphometric analysis to quantify the
microvascular response to bioactive borate glass in subdermal tissue excised from the
dorsum of the mouse. The third objective of this project involved measuring cytokine
expression in tissues in response to implantation of copper doped borate glass. The basic
hypothesis of this study is that 13-93B3Cu bioactive glass will stimulate expression of
the cytokine VEGF resulting in angiogenesis in the treated tissue.
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II.

MATERIALS AND METHODS

2.1

Experimental design
The experimental design of this project included experiments at three biological

levels (macroscopic, tissue, and molecular) to assess the microvascular response to
bioactive glass implants in a mouse model system. Two of the three experiments each
included ten mice with each animal receiving two subdermal implantations. The surgical
implantations in the first experiment included three different types of bioactive glass
beads plus the surgery without implantation (sham control). The second experiment
involved implantation of three types of glass microfibers plus sham control implantations.
The placement of implants was randomized with five replicates of each glass type and
five sham controls included in both of the first two experiments. Live transdermal
imaging of skin tissues with implants in place was performed at weekly intervals to
assess macroscopic responses to the implants. After three weeks, tissues were removed
from the implant sites for histological assessment of tissue responses. The third and final
experiment included a separate group of eight female mice that were used for assessment
of molecular responses to the implants. Each animal received two subdermal
implantations followed by re-anesthetization one week later to receive two additional
implantations and then, after another week, two additional implantations. There were six
total implantations per animal that included three 13-93B3Cu beads and three sham
implantations. At 1, 2, and 3 weeks post implantation these animals were euthanized and
tissues collected from the implant sites for isolation of total RNA which was used for
assay of gene expression.
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2.2

Bioactive glass composition and preparation
The bioactive glass materials utilized for subdermal implantation included two

types of silica-based glass, 45S5 glass and 13-93 glass, plus two borate-based glasses that
were designated 13-93B3 and 13-93B3Cu, all of which were provided by MO-SCI Inc,
Rolla, MO. Compositions of these four glasses are listed in Table I. The glass types
were used in two physical forms for implantation, plugs of compressed glass microfibers
and fused glass beads. Examples of these two types of implants are shown in Figure 1.
Batched glass microfibers (10.5 ± 0.5 mg) were compressed into the shape of 2 mm
diameter plugs using a specially constructed teflon mold with stainless steel rod inserts.
Each compressed plug was displaced from the teflon mold into a 200 µl glass
microdispenser tube (Drummond Scientific Company). As shown in Figure 1, the
compressed plugs are noticeably porous. The compressed glass microfiber plugs in glass
microdispenser tubes were sterilized by dry heating overnight at 300o C prior to
implantation. Bioactive glass beads were formed from the glass microfibers using a
butane torch (Benzomatic) and a graphite mold. Individual 10 mg ± 0.5 mg batches of
the glass microfibers were placed in the graphite mold and heated with the butane torch
to fuse the microfibers together to create a smooth spherical body. The individual beads
formed were weighed to confirm a mass of 10 mg ± 0.5 mg, checked under a stereoscopic
microscope to confirm smoothness plus absence of crystallization, and then dry heat
sterilized.
2.3

Dorsal window frame
Special dorsal skin window frames were fabricated from 0.45 mm thick aluminum

stock. Individual pieces of the aluminum stock were cut to dimensions of 25 mm x 15
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mm with two adjoining pieces used to form one frame. Two windows were bored in each
frame using an 8 mm drill bit with approximately 2 mm between the windows. The
edges of the window frames were smoothed and 5 smaller 1.5 mm diameter holes bored
for use for suturing the frame to the dorsum of the mouse.
2.4

Animals
Female 5 to 7 week old SKH1 mice (24 ± 4g) were obtained from Charles River

Laboratories and used in all experiments of this project. One unique characteristic of this
murine strain is the loss of hair around three weeks of age, a characteristic similar to
alopecia [37]. This phenotypic characteristic was a desirable feature for transillumination of the skin for observation of microvessels at weekly intervals. Mice were
housed in the Missouri S&T Animal Research Facility with free access to both food and
water. Animal protocols used in this project were pre-approved by the Missouri S&T
Animal Care and Use Committee and complied with all regulations of Office of
Laboratory Animal Welfare (OLAW). NIH guidelines for the care and use of laboratory
animals (NIH Publication #85-23 Rev. 1985) have been observed.
2.5

Surgical procedures
In preparation for surgery the animals were anesthetized by intraperitoneal

injection of a mixture of ketamine (16.7 mg/kg), xylazine (4 mg/kg), and acepromazine
(2 mg/kg). The dorsal surface of the mouse was disinfected with Betadine surgical scrub
followed by 70% alcohol. The mouse was placed on a sterile drape covering a
controlled-temperature stainless steel tray which was used to prevent a drop in body
temperature during anesthesia. Light was transmitted through a lifted fold of dorsal skin
via a bifurcated light source (Fostec Model 3115PS) to identify location of large vessels
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(as shown in Figure 2A). An indelible mark was made at the center point between the
major vessels for use as a reference when subsequently installing the skin window frame.
Fine scissors were used to make two 3 mm transverse incisions in the dorsal skin
approximately 8 mm cranial and 8 mm caudal to the reference mark. Phosphate buffered
saline (PBS; 3 µl) was pipetted into the incision to act as a lubricant to aid insertion of the
glass microdispenser delivery tube. After inserting the delivery tube, a sterile stainless
steel rod was used to displace the bioactive glass plug from the tube. A second plug was
implanted 8 mm caudally. The incision was closed using a minimal amount of superglue.
Following implantation of the glass microfiber plugs, a pre-sterilized dorsal
window frame was aligned such that the bioactive glass plugs were approximately in the
middle of each window of the frame. The two sides of each dorsal window frame were
sutured together with Ethicon 4-0 black nylon monofilament to hold the frame securely in
place and prevent movement (as shown in Figure 2B). Ketoprofen was administered
subcutaneously at a dose of 5 mg/kg following the completion of the surgery for pain
management.
The steps in the surgical implantation of the fused glass beads were performed
similarly to those used for the glass microfiber plugs. A single transverse 3 mm incision
was made at the mid-dorsal reference mark and PBS pipetted into the incision to act as
lubricant. A sterile bead was aseptically positioned at the lip of the incision and a sterile
200 µl pipette tip used to push the bead into the incision and approximately 8 mm
cranially. The second bead was similarly positioned and pushed into the incision
approximately 8 mm caudally. A dorsal window frame was then placed over the dorsal
skin fold, aligned with the implanted beads approximately in the middle of each window,
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and sutured into place as described above. The remaining steps of implantation were
similar. Following the completion of the surgical implantation and attachment of the
dorsal skin window frames, each animal received a subcutaneous injection of Ketoprofen,
5 m/kg, for pain management.
2.6

Live imaging through dorsal skin window
A plexiglass platform (approximately 25 cm x 35 cm) with 15 cm high support

leg was used during digital imaging of live tissues enclosed in the skin window frames.
To begin the imaging, an alert animal was placed in a tubular restraint device which was
then placed on the plexiglass viewing platform with the animal positioned on its side. A
light pipe below the platform was adjusted to project light through the skin enclosed in
the window frame. The focus ring of the 10x macrozoom affixed to the digital camera
mounted above the platform was adjusted to bring the trans-illuminated skin fold into
focus and digital images of the tissue were collected.
2.7

Tissue collection and processing for histology
At the conclusion of the three week implantations, animals were euthanized by

CO2 inhalation and the entire segment of whole skin at each implantation site was excised
with an 8 mm biopsy punch (Miltex). Immediately following excision, the implant
material (bead or plug) was carefully removed from the excised disc and the skin sample
then placed in ten volumes of 10% neutral buffered formalin. Following a four day soak,
the fixed tissue samples were rinsed in PBS and dehydrated through a graded series of
ethyl alcohol solutions. The fully dehydrated tissues were place in a programmable
vacuum tissue processor (Tissue-Tek Model VIP2000) for infiltration with paraffin. The
paraffin embedded samples were then sectioned at a thickness 5 µm with a Leica model
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RM 2235 microtome and the resulting tissues sections mounted on positively charged
microscope slides.
2.8

Histological evaluation and microscopy
Microscope slides containing the paraffin thin sections were deparaffinized in

xylene for five minutes followed by hydration in distilled water in preparation for
periodic acid Schiff (PAS) staining, the method chosen for histological definition of the
subcutaneous tissue samples. The hydrated tissue sections were immersed for five
minutes in 0.5% periodic acid solution, washed in distilled water, and then submerged in
Schiff reagent for 17 minutes followed by two washes (30 seconds each) in 0.55%
potassium metabisulfite to remove excess Schiff stain. Sections were then placed in room
temperature tap water to develop full color followed by 30 seconds of counter staining
with 1% solution of light green. Stained sections were washed with distilled water,
dehydrated in ethyl alcohol, cleared for five minutes in xylene, and a cover slip mounted
with synthetic resin (Permount-Fischer). This sequence caused the endothelial basal
lamina to stain dark blue by the PAS solution while erythrocytes were stained green by
the 1% light green counterstain thereby facilitating visualization of the microvasculature
[38].
The stained slides tissue sections were then examined by bright field illumination
under an Olympus BX53 microscope fitted with an Olympus DP70 camera. The entire
tissue sample section (approximately 8 mm x 8 mm) was initially imaged with a 4x
objective which was used to obtain overlapping 4x digital images. The ‘Photomerge’
tool of Adobe Photoshop CS3 was used to merge these images into one large composite
image of the entire stained section of tissue. Using other features of the Photoshop CS3
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software, the composite images was overlaid with a grid pattern. As explained in the
appendix, the grid was designed such that the area of the individual boxes of the grid
corresponded to the field of view seen under the 20x objective of the microscope. Using
the randomized selection scheme described in the Appendix, four separate boxes for each
tissue section were randomly selected for collection of the higher resolution digital
images with the 20x objective.
2.9

Image analysis and histomorphometry
ImageJ software was used for histomorphometric analysis of the four 20x digital

images of each tissue sample. The histomorphometry was started by making two
electronic copies of each digital image. The ‘pencil tool’ in the ImageJ program was
used to encircle all PAS-stained vessels visible in copy one, as shown in Figure 3. In a
similar manner all void areas without tissue were encircled in copy two. The pictures
were converted to binary images and further processed by using the ‘Analyze’ function to
measure the percentage of vessel area in copy one and the void area in copy two. Void
areas were subtracted from the total area (if applicable) and a percentage of vessel area to
total tissue area was calculated. The following equation was used to quantitatively
compare each of the different treatment glasses.
% Vessel area = (Vessel Area / Total Area-Void Area) x 100
2.10

Extraction of total RNA
A modified procedure of Chomczynski & Sacchi [39,40] was used to isolate total

RNA with strict attention to precautionary steps to avoid degradation of RNA by
inadequate cooling, contamination with RNases, and other problems. Immediately
following euthanasia by CO2 inhalation, full thickness skin at the implant site was quickly
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excised with an 8 mm biopsy punch and snap frozen in liquid nitrogen. The 10 mg
treatment beads were removed from the frozen tissue samples prior to pulverization.
Working under liquid nitrogen in a pre-chilled mortar and pestle, each frozen tissue was
pulverized into a fine powder that was placed in a 1.5 ml RNase-free microfuge tube and
held at -80oC. The pulverized tissue in each microfuge tube received a 400 µl volume of
guanidinium thiocyanate-phenol-chloroform extraction solution (TRIzol®) in which the
tissue was thoroughly homogenized using a motorized dental hand drill (Aseptico model
AEU-10) fitted with a disposable RNase-free pestle. Chloroform was added to the
TRIzol homogenate mixture which was separated to two phases by centrifugation at
12,000 x g. The upper aqueous phase was withdrawn and isopropyl alcohol added to
precipitate RNA which was then pelleted by centrifugation at 10,000 x g. The gel-like
pellet containing RNA was washed twice in RNase-free ethanol, partially dehydrated,
and finally suspended in 40 µl diethylpyrocarbonate (DEPC) treated water. Aliquots of
each sample were analyzed with a Nanodrop 3000 spectrophotometer to measure
absorbance at 260 nm and 280 nm for determination of A260/A280 ratio. Samples of total
RNA (1 µg) were also run on a 1% agarose/formaldehyde denaturing gel and, after the
electrophoresis run, were stained with SYBR-Gold nucleic acid stain. The agarose gel
containing total RNA aliquots was imaged to assess sharpness of the 18S and 28S bands
of ribosomal RNA and the extent of smearing.
2.11

Analysis of gene expression by quantitative PCR
Advance arrangements were made with an outside contract laboratory associated

with the Mouse Biology Program at the University of California-Davis for analysis of
gene expression by quantitative PCR (qPCR). Total RNA samples were packaged in dry
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ice and shipped overnight to the UC-Davis lab. The 12 RNA samples sent for analysis
included three samples of RNA from sham control tissues along with three samples of
RNA from week one, week two, and week three tissues treated with the 13-93B3Cu
glass. The samples were initially converted to cDNA. Custom constructed
oligonucleotide probes (TaqMan® probes) specific for the VEGF and FGF-2 target genes
plus the GAPDH gene (which was used as an endogenous control) were synthesized by
the UC-Davis lab in preparation for their qPCR assays of gene expression. The special
attribute of these TaqMan® probes is the inclusion of both a fluorophore and a quencher
moiety in the same molecule. Taq polymerase reaction mix plus duplicate aliquots from
each sample along with duplicate aliquots of each of each TaqMan® probe were pipetted
in the wells of a multiwall plate which was then placed in the qPCR thermal cycler
instrument. As product cDNA is amplified by the thermal cycling, the TaqMan® probe
is degraded to release the fluorophore which is then fluorescently excited by the
instrument light source. The thermal cycle at which the concentration of amplified
product cDNA is sufficient for detection above background is designated Ct (threshold
cycle), one of the units of measurement in the qPCR procedure [41]. The levels of gene
expression of target genes of each sample were compared to that of the GAPDH
endogenous control gene. The inclusion of an endogenous control, which is assumed to
be uniformly expressed in all tissue samples, was used to obtain ∆Ct values [42]. Delta
Ct values were calculated by subtracting the control sample Ct value from the
endogenous GAPDH control Ct value. Using ∆Ct values relative changes in gene
expression were also compared by using the delta-delta Ct calculation (as explained in
the Appendix) [42].

16
2.12

Statistical analysis
Data sets are presented as means ± standard error of the mean (SEM). Evaluation

of treatment groups from experiments was done by one way analysis of variance
(ANOVA) followed by the Tukey post-hoc test to identify significant differences
between treatment groups. Differences between group means were considered significant
with p-values less than 0.05 (p< 0.05) and moderately significant with p-values less than
0.10 (p< 0.10).
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III.

RESULTS

3.1

Imaging of localized tissue response to bioactive glass implants
The materials initially used for implantation in dorsal skin window preparations

for live imaging of localized tissue responses were compressed plugs of microfibrous
glass. It soon became clear, however, that the microfibrous plugs were injurious to the
local tissue. Signs of tissue injury that were seen in response to the microfibrous plugs
included the accumulation of pockets of fluid edema accompanied by an inflamed reddish
appearance in the surrounding tissue. The development of an inflamed appearance was an
unwanted artifact that would complicate the visualization of tissue responses including
the possible formation of new microvessels resulting from angiogenesis. In an effort to
reduce or eliminate the inflammatory response artifacts, it was decided to use spherical
beads of fused glass in subsequent implantations for live imaging. The rationale for
switching to fused beads was the premise that the smooth surface of the beads would
likely be less irritating than plugs of compressed glass microfibers, many of which have
exposed sharp ends that would cause tissue irritation.
Representative live macroscopic images of localized tissue responses to bioactive
glass beads implanted in dorsal skin window preparations and subsequently photographed
at one, two and three weeks after implantation are shown in Figures 4, 5, and 6,
respectively. Not included here are day zero images that were obtained within 30
minutes after implantation of the fused beads. The day zero skin window photos showed
minor inflammation that formed quickly around some of the fused beads although this
minor inflammation appeared to subside before the follow-up week one photos were
taken. Figure 4 shows an image representative of the dorsal skin windows at week 1
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post-implantation. There was little or no observable response with any of the implanted
beads except for minor redness surrounding one of the implanted 13-93B3Cu beads and
one 13-93B3 bead. The representative images in Figure 5 of tissue response at week 2
show a halo-like body surrounding a 13-93B3 bead and an even more prominent halo
around a 13-93B3Cu bead. The halos around the beads at week 2 extended approximately
1 mm beyond the edge of the bead, a finding also observed with the other borate beads
that were implanted. The representative week 3 skin window sample shown in Figure 6
reveals a clear difference in response to the borate-based glass bead and the silicate-based
glass bead. The borate-based 13-93B3 bead has a distinct and localized halo response
around the implant. In contrast, the silicate-based 13-93 glass beads produced little or no
discernable response. Overall, the outcome of the live imaging was the finding of
essentially no new vessels nor increased microvascular density visible in tissue
surrounding the 13-93 glass beads while tissues implanted with the borate-based 13-93B3
and 13-93B3Cu beads showed increased redness and halo formation. A tabulated
summary of qualitative scoring of the responses of soft tissue to borate and silicate-based
beads in dorsal skin windows is presented in Table II. As indicated in the table, a distinct
halo-like body was observed around only one of the five 13-93 silicate glass beads at
week 3. In contrast, distinct halos were observed at week 3 around three of the five
implanted 13-93B3 beads and two of the three remaining 13-93B3Cu beads. The halos
surrounding the borate-based 13-93B3 and 13-93B3Cu beads had an outer diameter of
approximately 3-4 mm, became prominent at week two, and remained distinct until the
animals were sacrificed at week three.
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In addition to the sample images of response to separate beads as shown in
Figures 4-6, the photo images in Figure 7 show a three week progression of tissue
responses to an implanted13-93 bead and a 13-93B3 bead. Figure 7A and 7B show week
zero pictures obtained within 30 minutes after implantation. Minor inflammation caused
by the bead insertion was observed with the 13-93B3 bead, although this subsided before
the subsequent photos at week 1. The week 1 response visible in Figure 7C and 7D
reveals little or no tissue response around either of the two beads. Figure 7E and 7F
compares the localized tissue response around the two different beads at week 2. As
shown in this comparison, there is a prominent halo response around the borate-based 1393B3 bead but not around the 13-93 bead. The tissue responses appear virtually the same
at week 3 as shown in Figures 7G and 7H. Another interesting morphological feature
noticed in this three week sequence of photos is an increasing prominence of the large
vessels near the 13-93B3 bead.
A follow-up side experiment was conducted to further characterize the halo
structures. The follow-up included a separate group of 10 SKH1 mice that received
subdermal implantations of 13-93, 13-93B3, and 13-93B3Cu fused beads without the use
of the skin window frames. The objective of this approach was macroscopic viewing of
tissue responses in a more direct manner from the subdermal side of necropsied skin
rather than by repeat indirect viewing from the epidermal side of intact live skin enclosed
within the dorsal skin window preparations. Three weeks after implantation, the animals
were euthanized, a mid-dorsal incision was made, and the skin reflected for direct,
macroscopic photo imaging of subdermal soft tissue. Three of the four sham
implantation sites were no longer detectable when examining the subdermal surface at
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three weeks post implantation while at the one sham site that was still somewhat
discernable there was only a very small (<1 mm diameter), slightly reddish body. The
outcome with the beads, as shown by the photo images in Figure 8, was the finding of a
reddish, halo-like structure surrounding each of the four implanted 13-93B3Cu beads and
each of the four implanted 13-93B3 beads but no similar halo response at any of the four
sites with 13-93 beads. As shown, the halo-like structures surrounding the 13-93B3Cu
beads were more intense than the halos surrounding the 13-93B3 beads. It was noticed
that the distinct halo around the 13-93B3Cu beads included well delineated microvessels.
Furthermore, the halo structures around 13-93B3Cu beads (as viewed here from the
subdermal surface of the necropsied skin) were about 4 mm in diameter and similar to the
halo-like structures observed from the epidermal side in the live dorsal skin window
preparations. In addition to the tissue response, the physical appearance of the implant
was also observed. At three weeks post implantation the glass beads were intact,
appeared to be the same diameter as when initially implanted, and had no noticeable
reacted layer on their surface.
3.2

Sample recovery and histological evaluation of soft tissue response
At conclusion of the three week implantation, discs of whole skin were excised

from the dorsal skin fold preparations and the implants immediately examined. The
microfiber plug appeared approximately the same size after three weeks but was covered
with a thin white reacted layer. In addition, the plugs were soft, moist, and crumbled
upon removal. The glass beads appeared to be the same diameter as when initially
implanted, they were completely intact upon removal, and there was no observable white
reactive layer on their surface. After processing and staining the tissue samples, digital
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photos were taken with the 4x objective of separate area of the stained tissue sections and
the 4x images digitally combined to form a low magnification, composite image of the
entire tissue section as explained in the Materials and Methods. An example of this is the
image shown in Figure 9, a composite image of tissue from a dorsal skin fold preparation
implanted with a 13-93B3Cu bead. Included in the figure are two enlarged areas that
show the relative density of microvessels at the periphery (Figure 9A) of the tissue
section and also near of the former site of the implanted bead (Figure 9B). Comparison of
the two enlarged areas appears to show a higher density of microvessels proximal to the
bead. This finding is consistent with the microvessel-containing halo that was observed
around each of the 13-93B3Cu beads that were seen both in the live skin window
preparations and in the necropsied skin samples as described above.
Using the randomized selection procedure mentioned in Materials and Methods
(and described in detail in the Appendix), four fields within each tissue section were
selected for digital imaging at higher magnification through the 20x objective. The four
panels of Figure 10 show representative 20x images of PAS-stained sections of
subdermal tissues removed three weeks after implantation of fused glass beads. The sham
control sample shown in Figure 10A, which is representative of the subdermal tissues
recovered from sites where no bead was implanted, shows adipose and areolar tissues
with a low microvascular density. The image in Figure 10B is a representative example
of tissue with the silicate-based 13-93 glass bead. The tissue shown here has a
microvascular density that is similar to that of sham control tissue. Microvessels can be
seen along with fibrous tissue on the right side of the image. Sections of soft tissues from
the 13-93B3 and 13-93B3Cu implantation sites are shown in Figures 10C and 10D,
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respectively. The tissue with the borate-based 13-93B3 bead (Figure 10C) appears to
contain increased fibrous tissue plus a qualitatively higher density of microvasculature.
The tissues from implants sites with the 13-93B3Cu glass appeared qualitatively to
contain the highest density of microvessels. Minor amounts of fibrous tissue were
observed throughout tissues with the 13-93B3 and 13-93B3Cu beads, a finding
representative of other replicates. Many of the small microvessels visible in Figure 10D
appear approximately the same diameter as an erythrocyte indicating that they are
capillaries. The histological evaluation revealed that the replicate tissue samples
recovered from the other sites of implantation of 13-93B3Cu glass beads also appeared
qualitatively to have the highest density of microvessels.
The four panels of Figure 11 show representative 20x images of PAS-stained
sections of subdermal tissues removed three weeks after implantation of glass microfiber
plugs. Figure 11A is representative of the subdermal tissues recovered from sham control
sample. This panel shows adipose and areolar tissues with a low microvascular density
and is similar to the sham control samples above. The image in Figure 11B is a
representative example of tissue implanted with silicate-based 45S5 glass microfibers.
The section shown here has a tissue composition similar to that of sham control sample
and a similar microvessel density. Representative images of soft tissues from the sites of
implantation of 13-93B3 and 13-93B3Cu glass microfibers are shown in Figures 11C and
11D, respectively. The image in Figure 11 of tissue with the borate-based 13-93B3 glass
microfibers appears to qualitatively show a slightly higher microvessel density, a
difference also discernable in the other tissues with this type of glass microfibers. The
tissues from implants sites with the 13-93B3Cu glass qualitatively appeared to contain
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the highest density of microvessels as localized tissue response. Moderate amounts of
fibrous tissue were observed in tissues with both types of borate-based microfibrous
plugs. More microvessels can be observed in all of the treatment tissues with
microfibrous plugs, but the 13-93B3Cu glass microfibers appeared qualitatively to
promote the highest microvessel density in the surrounding tissue. As in the case above,
the histological evaluation revealed that the replicate tissue samples recovered from the
other sites with 13-93B3Cu glass microfibers also appeared qualitatively to contain the
highest density of microvessels.
3.3

Quantitative histomorphometry
A summarized comparison of the microvessel density in soft tissue recovered

from the sites of implantation of bioactive glass beads and glass microfiber plugs is
presented in Table III. The quantitative histomorphometric measurements reveal that all
implantations of bioactive glass, both in the form of beads and in the form of compressed
microfiber plugs, resulted in higher microvessel densities than those of the sham control
tissues. The total vessel areas observed in the two groups of sham control tissues were
both calculated to be 2.6% of the total observed tissue area. Implantation of the fused
glass beads and glass microfiber plugs resulted in the same overall trend for the tissue
microvessel densities which were observed to be: lowest in the sham control tissues;
slightly higher in tissues with silicate-based 13-93 or 45S5 glass; higher yet in tissues
with 13-93B3 glass beads and glass microfibers; followed by the highest microvessel
densities in tissues with 13-93B3Cu glass beads and glass microfibers. The tissues
implanted with the 13-93, 13-93B3, and 13-93B3Cu glass beads showed 33%, 58%, and
145% higher microvessel density values relative to the three-week sham control tissues,
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respectively. In a similar manner, the tissues containing 45S5, 13-93B3, and 13-93B3Cu
glass microfiber plugs were found to have microvessel densities that were 56%, 124%,
and 171% higher, respectively, compared to the three week sham control tissues.
The two bar charts in Figure 12 provide graphical representation of the mean microvessel
densities with statistical analysis of differences between the treatment groups. Results of
the ANOVA test revealed the differences between the mean values of the various groups
were greater than would be expected by chance and significant at the p<0.05 level. A
Tukey HSD post-hoc test was performed as a follow up to test for significant differences
between individual treatment groups. The Tukey test indicated that the higher
microvessel densities of soft tissues with 13-93B3Cu glass beads or glass microfiber
compared to microvessel densities of the sham control tissues was statistically significant
at the p<0.05 level. The higher microvessel densities of tissues with 13-93B3 glass beads
or glass microfiber compared to sham control tissues were found to be marginally
significant at p<0.10. In contrast, the microvessel densities of tissues with silicate-based
45S5 and 13-93 glasses were not statistically different than those of the sham control
tissues.
3.4

Analyses of total RNA extracts
The yields of total RNA extracted from the frozen skin samples were, as

expected, rather low with values ranging from 120 ng/µl to 276 ng/µl for aliquots
suspended in DEPC-treated water. The integrity of the total RNA extracts was evaluated
by spectrophotometry and gel electrophoresis. The average A260/280 ratios for total
RNA from sham control and from the 13-93B3Cu wk1, 13-93B3Cu wk2, and 13-93B3Cu
wk3 skin samples were 1.88, 1.85, 1.82, and 1.87, respectively. Aliquots (1 µg each) of
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total RNA were loaded on 1% agarose/formaldehyde denaturing gels, subjected to
electrophoresis, and the resultant separated bands then stained with the nucleic acid dye
SYBR-Gold. Figure 13 shows a representative 1.0% agarose formaldehyde gel loaded
with 1µg of total RNA in one lane plus an aliquot of standard 500-9,000 base
oligonucleotide ladder in a separate lane. As shown, there are two intense bands at
approximately 5 kb and 1.9 kb that correspond to 28S rRNA and 18S rRNA, respectively,
plus a near absence of smearing. The presence of sharp 18S and 28S bands along with
nearly complete absence of smearing was also seen in all of the other preparations of total
RNA extracted from frozen skin samples, findings that confirm the integrity of the RNA
preparations.
3.5

qPCR analysis of gene expression
The results for all qPCR gene expression assays were obtained by an outside

contract laboratory associated with the Mouse Biology Program at the University of
California-Davis. The assays were performed on twelve RNA samples that included three
samples of sham control RNA along with three samples of RNA from week one, week
two, and week three tissues treated with the 13-93B3Cu glass beads. As indicated in the
Materials and Methods section the RNA samples were converted to cDNA through
reverse transcription and custom TaqMan® probes specific for VEGF and FGF-2 target
genes plus the GAPDH endogenous control gene were synthesized by the UC-Davis lab.
Duplicate aliquots of the probes, cDNA from each sample, and other necessary reaction
components were pipetted into the wells of a multiwall plate and placed in a thermal
cycler instrument. As the qPCR continues and newly-formed product cDNA matching the
target gene is synthesized, florescence is detected at a critical threshold (Ct) as explained
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in Section 2.11. The thermal cycle number at which Ct is reached was determined. The
Ct values of VEGF, FGF-2, and sham control were normalized to the Ct values of
endogenous GAPDH controls. Gene expression values are then listed as delta-Ct values
(as given in Table IV), or the Ct difference between the endogenous control and target
genes. Relative FGF-2 expression showed changes at weeks one through three of 0.53,
0.81, and 0.93, respectively (shown in Figure 14A) with no statistically significant
difference compared to the sham control. VEGF expression showed fold changes of
0.78, 1.12, and 1.80 during weeks one through three, respectively, as shown in Figure
14B. Statistical analysis, including a one way analysis of variation (ANOVA) followed
by a student t-test was performed on the delta-Ct values from each treatment group. The
VEGF expression data showed that there was marginally significant difference at the p
<0.10 level (p = 0.057) between the sham control and 13-93B3Cu week 3 values.
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IV.

DISCUSSION

Current procedures and materials for wound treatment have yielded relatively
poor outcomes with chronic skin wounds, a major health care challenge. In that sense, the
new treatment procedure recently tested in a clinical study at the Phelps County Regional
Medical Center (PCRMC) is a noteworthy exception. This new procedure involved
treatment of venous stasis wounds with dressings composed of borate-based glass
microfibers [35]. The results of the PCRMC clinical trial were a dramatic improvement in
the healing of previously non-responsive wounds for most of the volunteers enrolled in
the study. The borate-based glass microfiber treatments were very encouraging, but mode
of action in the wound healing process was not addressed. Related rodent model studies
from two different laboratory groups at Missouri S&T investigated the possible
angiogenic effects of bioactive borate-based glass materials. One study involving
subcutaneous implantation of sintered glass fiber scaffolds reported an increased density
of vessels around and within scaffolds composed of copper-doped borate glass fibers
compared to those without copper [43]. The second study reported a dramatic increase in
the microvessel density of subcutaneous tissues with borate-based glass microfiber
implants compared with sham-implanted, blank control tissues [36]. Both projects
revealed an angiogenic effect of the borate-based glasses although the underlying
mechanism of angiogenic effect was not investigated.

This project was undertaken to specifically address the physiological and
molecular mechanism of the angiogenic effect of borate-based glass materials. An
original intention in the use of trans-illuminated skin window preparations was to achieve
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sufficient resolution for clear delineation of microvessels that might form in response to
the implant. The level of resolution that was obtained during live imaging through the
skin folds was not sufficient to permit consistent delineation of microvessels. As a
consequence, the live images were not suitable for quantitative histomorphometric
measurements with image analysis software. The imaging did, however, allow
unambiguous recognition of differences in the extent of the soft tissue responses to the
borate-based glass beads and the silicate-based glass beads which were assessed
qualitatively. As described in the Results section, much of the live soft tissue response
observed around the borate-based beads involved the formation of a halo body. In the
few images with sufficiently high resolution, the halo bodies were recognized to be tissue
clusters infused with microvessels. And, the formation of microvessel clusters or halo
bodies observed around the 13-93B3 and 13-93B3Cu beads is consistent with the
formation of granulation tissue that was observed in the PCRMC clinical study [35].

The interpretation that the halo observed in the live image were mostly composed
of microvessel-rich soft tissue was supported by the necropsy images obtained at 3 weeks
post-implantation. The necropsy examination revealed clearly delineated microvessels
visable within the reddish mass found around some of the implanted beads. Furthermore,
the reddish mass encircling the borate-based glass beads of the necropsy samples was
approximately the same size as the halo bodies observed during live imaging of the dorsal
skin folds, appeared most prominent around the 13-93B3Cu glass bead, and virtually
absent with the silicate-based 13-93 glass beads. Also noticed in the necropsy samples
were vessels ‘budding’ toward some of the 13-93B3Cu glass bead, an indication of
angiogenesis.
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The results of histological evaluation of the PAS-stained tissue sections also
support the interpretation that the halo bodies surrounding the borate glass beads were
tissue clusters infused with microvessels. As mentioned, the microvessel densities
observed here were found to be higher within about a millimeter of the implanted borate
bead compared to areas distal to the bead. This finding agrees with the higher
microvessel densities observed around subcutaneously implanted plugs of 13-93B3Cu
glass microfibers as reported in the related similar in vivo investigation by Lin et al. [36]

Close inspection of the table of histomorphometry results reveals a difference in
the extent of the angiogenic response to glass microfibers plugs and beads. Higher
microvessel densities were observed around the microfibrous plug than the fused glass
bead. This difference can in part be attributed to the difference in surface area of the two
physical forms of the glass implants. The plugs composed of borate glass microfibers
with nominal diameters of approximately 2-5 µm have a much higher surface area than
the 2 mm in diameter. The micron diameter fibers react completely in three weeks
[34,43] releasing all of the boron and copper. The glass bead did not appear to have a
reacted surface layer, another indication of slower dissolution.. Due to the diameter of
their component fibers together with moderate porosity, the microfibrous plug would
have a vastly higher surface area which contributes to fast dissolution resulting in higher
localized concentrations of borate and copper, the angiogenic ions [44-47].
The extent of the angiogenic response to the borate glass plugs and beads used in
this study was about two-thirds of level of the angiogenic effect of microfibrous bioactive
borate glass used in the previous study by Lin [36]. This reported difference in
angiogenic response may in part reflect the different methods of randomly selecting
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candidate areas for measurement of vessel densities in the stained slides. The method
used in this project involved randomly selecting candidate fields from a grid overlay
composite image of the entire sample. In contrast, the method used in the previous study
involved unbiased selection of areas that were within approximately a millimeter of the
microfibrous glass implant [36]. The inclusion of area for enumeration distal to the
implant, as was done in this project, would quite clearly cause the overall observed
angiogenic effect to be less.
The effects of borate-based bioactive glass on expression of vascular endothelial
growth factor (VEGF) in vivo had not been investigated prior to this study. Thus, an
important and novel aspect of this investigation is the finding of elevated expression of
VEGF mRNA in skin tissue after three weeks with the 13-93B3Cu glass beads in place.
Many growth factors have been shown to be involved in wound healing, but VEGF has
been identified as having an especially important role [48]. And, the 13-93B3Cu beads
did trigger a 1.8-fold increase in VEGF expression after three weeks. Fibroblast growth
factor-2 (FGF-2) has also been reported to be important in vasculogenesis [55]. However,
the results of this study indicated there was no increase in expression of FGF-2 mRNA in
response to the 13-93B3Cu glass beads. The relatively modest increase in VEGF
expression after three weeks in response to the 13-93B3Cu beads is likely related to a
slower dissolution of the glass beads. It might be anticipated that a higher level of VEGF
expression would likely occur in response to implantation of more rapidly dissolving 1393B3Cu glass microfiber plugs.
Collectively, the results of this project demonstrate that the borate-based bioactive
glass beads and microfiber plugs do promote angiogenesis, an essential step in wound
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healing. These positive results provide additional evidence that these materials are
potentially useful for treating chronic non-healing wounds. An important outcome was
the finding that copper-doped 13-93B3Cu glass is able to stimulate VEGF expression
which would promote angiogenesis. This finding suggests a bioactive borate glass
implant would be a simple but effective vehicle for delivery of pro-angiogenic ions and,
as a result, an attractive alternative to expensive growth factors for treatment for chronic
wounds. Additional work is needed to determine if expression of other angiogenic
cytokines might also occur as part of the response of soft tissue to 13-93B3 bioactive
glass doped with various leachable ions.
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V.

CONCLUSION

The live imaging of dorsal skin window preparations in the hairless SKH1
showed the formation of a halo-like structure infused with vessels in soft tissue
surrounding borate-based 13-93B3 and 13-93B3Cu glass beads two weeks after
implantation. This response was not observed around silicate-based 13-93 glass beads.
Histological examination of the soft tissue recovered three weeks after implantation
revealed statistically significant increase (state them) in the microvessel density at
implant sites with 13-93B3Cu glass microfibers. Quantitative PCR measurements
indicate a marginally significant increase in expression of VEGF mRNA in skin tissues
with 13-93B3Cu. This latter outcome partially marginally supports the project hypothesis
that 13-93B3Cu glass induces VEGF expression followed by neovascularization, a key
process of wound healing.
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APPENDIX A
Procedure for random selection of grid overlay areas for measuring microvessel
density
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Each stained tissue section was initially imaged under the 4x objective and
multiple overlapping 4x digital images were obtained to form one large composite image
of the entire tissue section. A sequentially numbered grid pattern created with Microsoft
PowerPoint was then over layered onto the composite 4x image as shown in Figure 15B.
The grid was scaled such that individual boxes of the grid cover an area equivalent to the
field of view under the 20x objective. Each field within the grid was examined under the
20x objective to assess relative amounts of subdermis, the skin layer in which the
microvasculature is located. Fields containing less than 50% subdermis were excluded.
Also excluded from the grid were boxes devoid of tissue. For the example presented here,
the remaining candidate fields are those corresponding to the remaining numbered boxes
shown in Figure 15C. The numbers identifying the candidate fields were entered in a
Microsoft Excel file and the ‘=RANDBETWEEN’ function of Excel then used to
randomly select four numbers from the file. For the example presented here, the four
fields selected (i.e., the four 20x fields randomly selected for quantitative measurement of
microvessel density) are indicated by the highlighted numbers boxes shown in Figure
15D.

APPENDIX B
The delta-delta Ct calculation
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The delta-delta Ct (comparative CT calculation method) is a method of
quantitation of relative gene expression [42]. Total RNA is converted into
complementary DNA (cDNA) through polymerase chain reaction (PCR) which amplifies
specific target regions of cDNA through repeated cycles of separation and annealing the
two strands of DNA. The first step in the determination of relative gene expression is
quantitating the fractional number of thermal cycles at which a detectable signal is
observed for the target genes (VEGF and FGF-2) in the PCR process. This number of
cycles at which the target region of cDNA is sufficiently amplified is designated the Ct
value (threshold cycle). The Ct value is somewhat are counterintuitive because the lower
the Ct value the greater the amount of starting material (mRNA template for the target
gene) in the sample. The average Ct value is calculated for both the target genes and the
endogenous GAPDH control gene. The difference between the endogenous control and
the target gene is designated ∆Ct and is equal to the mean Ct value for each target gene
minus the mean Ct value for the endogenous GAPDH control. This ∆Ct value is the
basis for all subsequent data transformations via the delta-delta Ct calculation. Each
∆∆Ct value represents the difference between the ∆Ct value for a target gene in a treated
tissue sample minus the ∆Ct value for the same target gene in a sham control tissue
sample. Finally, a 2^(-∆∆Ct) value is calculated by the equation below:
2^(-∆∆Ct) where ∆∆Ct = ∆Ct treated tissue – ∆Ct control tissue
In typical cases in which the ∆Ct value of the treated tissue is less than the ∆Ct
value of the control tissue, the ∆∆Ct value is negative and the resultant 2^(-∆∆Ct) value
is positive. The calculation of 2^(-∆∆Ct) values is now widely used by the numerous
research laboratories that routinely measure gene expression levels. Additionally, it has
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been established that calculated 2^(-∆∆Ct) values are approximately equivalent to the
fold-change difference in gene expression as calculated by quantitative comparison to a
standard curve with known amounts of cDNA standard [41].
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Table I- Composition of bioactive glasses used for sub-dermal implantations
(composition values listed as wt %)

Glass

SiO2

B2O3

Na2O

CaO

MgO

K2O

P2O5

CuO

45S5

45.00

0

24.50

24.50

0

0

6.00

0

13-93

53.00

0

6.00

20.00

5.00

12.00

4.00

0

13-93B3

0

53.00

6.00

20.00

5.00

12.00

4.00

0

13-93B3Cu

0

52.79

5.98

19.92

4.98

11.95

3.98

0.40
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Table II. Qualitative evaluation of soft tissue response to beads implanted in dorsal skin
window preparations.

Implant
interval
1 wk

2 wk

3 wk

Bead
type

Beads (shams)
implanted

Beads (shams)
remaining

Fraction
with halo

Halo
density*

none (Sham)

(5)

(4)

0/4

0

13-93

5

5

0/5

0

13-93B3

5

5

0/5

0

13-93B3Cu

5

4

1/4

+

none (Sham)

(5)

(4)

0/4

0

13-93

5

5

0/5

0

13-93B3

5

5

3/5

++

13-93B3Cu

5

4

3/4

++

none (Sham)

(5)

(3)

0/3

0

13-93

5

5

1/5

+

13-93B3

5

5

3/5

++

13-93B3Cu

5

3

2/3

++/+++

* Key to qualitative assessment of halo density:
0
+
++
+++

No halo observed
Minor redness surrounding glass bead
Complete halo surrounding glass bead
Intense halo surrounding bead
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Table III. Quantitative histomorphometric comparison of microvessel densities in tissues
at three weeks post implantation. Vessel density values are expressed as area percentage
of total tissue observed in the 20x field. Each vessel density value is a mean ± SEM for
five replicate tissue samples.

Form of implant

Treatment glass

Vessel area
% of 20x field

Fold change relative
to sham control

Glass bead

None (sham control)

2.6 ± 0.1

1.0

13-93

3.5 ± 0.4

1.3

13-93B3

4.2 ± 0.3

1.6

13-93B3Cu

6.4 ± 0.9 **

2.5

None (sham control)

2.6 ± 0.3

1.0

45S5

4.1 ± 0.1

1.6

13-93B3

5.9 ± 0.8 *

2.3

13-93B3Cu

7.1 ±1.4 **

2.7

Microfiber plug

*
**

Group mean significantly different from sham control at the p < 0.10 level
Group mean significantly different from sham control at the p < 0.05 level
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Table IV. Quantitative PCR measurements of cytokine gene expression in skin tissues
with sham or borate bead implants. The ∆Ct values represent differences between target
gene and endogenous control gene expression; each ∆Ct value is a mean ± SEM for three
replicate tissue samples. The ∆∆Ct values represent fold changes of target gene
expression relative to a sham control.

Target
gene

Bead
type
implanted

Implant
duration
(weeks)

Mean
∆Ct
n=3

Mean
∆∆Ct
value

FGF2

none (Sham)

2

8.4 ± 0.3

1.00

13-93B3Cu

1

9.3 ± 0.3

0.53

13-93B3Cu

2

8.5 ± 0.3

0.81

13-93B3Cu

3

8.4 ± 0.3

0.93

none (Sham)

2

4.8 ± 0.2

1.00

13-93B3Cu

1

5.2 ± 0.2

0.78

13-93B3Cu

2

4.7 ± 0.1

1.12

13-93B3Cu

3

4.0 ± 0.3*

1.80

VEGF

* Group mean significantly different from sham control at p < 0.10
It is helpful to note that ∆Ct is inversely proportional to amount of target gene
mRNA present in the sample extract.
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Figure 1. Two separate physical forms of the bioactive glass samples implanted in mice.
(A) Compressed 2 mm diameter plugs of glass microfibers (side view); (B) fused 2 mm
diameter glass bead. Both samples shown here are 13-93B3Cu glass.
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A

B

Figure 2. Lifting of dorsal skin fold and installation of skin window frame in SKH1
hairless mice. (A) viewing major transverse vessels in skin fold; (B) mouse immediately
after surgical implantation of beads and attachment of skin window frame.
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B

A

100 µm

C

100 µm

D

100 µm

100 µm

Figure 3. Steps of image processing for histomorphometry of microvascular density
in soft tissues. (A) Original color photomicrograph of PAS-stained tissue; (B) Visible
blood vessels encircled; (C) Image converted to 16-bit, and the threshold adjusted to
highlight encircled area, and image converted to binary. (D) Encircled areas filled with
black and filled area measured with ImageJ software.
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13-93B3
13-93B3

13-93B3Cu
13-93B3Cu

Figure 4: Representative live photo image of localized tissue response to bioactive
beads at 1 week post-implantation. Enlarged areas show only little or no halo
response around the implanted beads. Scale bars represent 1.0 mm.
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13-93B3Cu

13-93B3

13-93B3Cu

13-93B3

Figure 5: Representative live photo image of localized tissue response to bioactive
beads at 2 weeks post-implantation. Enlarged areas show a prominent halo-like
structure surrounding the 13-93B3Cu bead. Scale bar represents 1.0 mm.
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13-93

13-93B3

Figure 6: Representative live photo image of localized tissue response to bioactive
beads at 3 weeks post-implantation. Enlarged areas show prominent halo around the
borate bead; none around the silicate bead. Scale bar represents 1.0 mm.
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13-93B3 bead

13-93 bead

A

B

C

D

E

F

G

H

Wk 0

Wk 1

Halo

Wk 2

Wk 3

Figure 7. Comparison of three week progression of tissue responses to implantation
of 13-93 bead and 13-93B3 bead. Arrows denote halo-like structure around 13-93B3
bead that became prominent at two weeks. Arrowheads point to increasingly
prominent larger vessels.
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Figure 8. Representative 3 week photo images of beads implanted subdermally
without skin window frames. Beads were photographed from the subdermal side
rather than by indirect viewing through the skin from the epidermal side. The types
of glass beads implanted were: (A-B) 13-93; (C-D) 13-93B3; and (E-F) 13-93B3Cu.
Scale bar represents 1 mm.
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Previous site
of implanted
bead

A

B

Figure 9. Composite images of soft tissue from a dorsal skin fold implanted with 1393B3Cu bead. Enlarged area shows relative density of microvessels three weeks post
implantation at periphery (A) and near the implanted bead (B). Scale bar represents
1.0 mm.
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Figure 10. Representative 20x photo images of PAS-stained sections of tissue recovered
after 3 weeks from subcutaneous sites of implantation of fused bioactive glass beads. The
types of glass beads implanted were: (A) none (sham control); (B) 1393 glass; (C) 1393B3 glass; and (D) 13-93B3Cu. Arrows point to some of the microvessels seen in the
tissues.
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Figure 11. Representative 20x photo images of PAS-stained sections of tissue
recovered after 3 weeks from subcutaneous sites of implantation of bioactive glass
microfibers. The types of microfibers implanted were: (A) none (sham control); (B)
45S5 (C) 13-93B3; and (D) 13-93B3Cu. Arrows point to some of the microvessels
seen in the tissues.
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Figure 12. Statistical comparison of vessel densities three weeks post implantation in

response to (A) fused bioactive glass beads and (B) microfibrous plugs. Values are
means + SEM for five replicates with each material. Asterisks (*) identify group
means significantly different from sham control at p < 0.05.
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RNA ladder
standard

total RNA extract
sample

28S rRNA
18S rRNA

Figure 13. Comparison of agarose gel banding patterns of a sample RNA extract and
a ladder standard. Bright bands in gel lane with extract denote positions of 28S and
18S ribosomal RNA.
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1.8
1.4

VEGF
gene

*

1.0
0.6

-∆∆Ct

2
value
1.4
1.0
0.6
0.2

Figure 14. Relative quantitation of FGF-2 and VEGF target genes using the deltadelta Ct calculation. Values are for three replicate with each implant duration.
Asterisks (*) identify group means significantly different from sham control at
p < 0.10
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Figure 15. Steps of randomly selecting 20x fields for quantification. (A) Composite
image of PAS-stained
stained tissue; (B) Grid overlay scaled such that each box represents a
20x field; (C) Array of qualifying candidate subdermal field for quantification; (D)
Four selected
ected subdermal fields to be assessed.

63

VITA

Richard Jeffrey Watters was born in McAlester, Oklahoma to Christopher and
Lori Watters. He graduated from Vicenza High School in Vicenza, Italy in 2004. He
graduated from Missouri University of Science and Technology in the Fall of 2011 with a
B.S. in Biological Sciences. In the Spring of 2012 he began his graduate degree under
Dr. Roger Brown at Missouri University of Science and Technology in the Spring of
2012. He received his Master of Science degree from Missouri University of Science and
Technology in May 2014.

